Sosei Heptares Acquires Idorsia’s Pharmaceuticals Business in Japan and APAC (ex-China), Accelerating its Transformation into a Fully Integrated Biopharmaceutical Company
Transaction adds complementary late-stage clinical development capability with profitable and fast-growing commercial operations in Japan
Lean, go-to-market commercial model, well positioned to scale rapidly to generate significant value from Japan and APAC (ex-China) geographic expansion
Includes Japan and APAC (ex-China) rights1 to two life-changing medicines with significant growth potential:
PIVLAZ® (clazosentan;…
The results from Eli Lilly's Phase 3 trial of Donanemab showed that the drug significantly slowed cogntive and functional decline for early symptomatic Alzheimer's disease patients, decreasing their risk of disease progression. Their recent press release stated that "nearly half of participants at earlier stage of disease on donanemab had no clinical progression at 1 year".
This study demonstrates the importance of an early diagnosis and brings hope to people with Alzheimer's disease.
Read the full press release.
Are you a vegan or vegetarian woman, at least 18 years old, live within 40 miles of Norwich and in good health?
The Quadram institute are conducting a 17-week study to investigate the use of hydroponically-grown, biofertified salad greens, and use of a dietary app, on iron and B12 status in vegan or vegetarian women of child-bearing age.
Interested in taking part? Find out more information and how to register your interest here.
PrecisionMed developed and manages the largest, private, global repository of longitudinally collected human cerebrospinal fluid (CSF) samples for scientific research
BioIVT, a global research partner and biospecimen solutions provider for drug and diagnostic development, announced today that it has acquired PrecisionMed, LLC, a leading supplier of high-quality human biological material for genetics, drug discovery, and biomarker research and in vitro diagnostics.
Based in Carlsbad, CA, PrecisionMed has been collecting biospecimens for neurology and oncology research for more than 27 years…
Oxford, UK, 18 July 2023 – PrecisionLife, a leading computational biology company driving precision medicine in complex chronic diseases, has announced the results of its long COVID study, providing the first detailed genetic insights into the condition and its commonalities with other diseases, including myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). This analysis opens the door for new precision diagnostic and therapeutic approaches to address the massive unmet medical need affecting the lives of millions of patients.
Long COVID is a debilitating chronic condition that has…
CAMBRIDGE, England & BOSTON, Jun. 23, 2023-- Bicycle Therapeutics plc (NASDAQ:BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today announced the appointment of
Alethia Young as its new Chief Financial Officer, effective July 17th.
Ms. Young joins Bicycle from Graphite Bio, where she served as Chief Financial Officer, and previously served as senior biotech analyst and head of research at Cantor Fitzgerald.
“We are…
Abzena have announced the recent appointment of Thomas Castellano as Chief Financial Office (CFO). Abzena is a leading biopharmaceutical company headquartered at Babraham Research Research Campus in Cambridge, UK. Last year, they opened a new biologics testing laboratory in San Diego, near their Biologics process development and manufacturing hub.
Castellano brings extensive financial expertise and strategic leadership to the company, having previously held the position of Senior Vice President, CFO at Catalent. His role as CFO will involve overseeing Abzena's financial…
AMSBIO, a leading supplier of human cell lines and research tools, is proud to announce its collaboration with WARR Space Labs, a student group from the Technical University of Munich (TUM). The students undertook an exciting project aimed at advancing our understanding of neurodegenerative disorders, particularly Alzheimer’s disease, through spaceborne experiments.
The aim of the ADDONISS (Ageing and Degenerative Diseases of Neurons on the ISS) project is to conduct research on neuronal cell cultures in the microgravity environment of the International Space Station (ISS). AMSBIO’s…
Experts in translational oncology and targeted protein degradation join Dr Simon Cook, Dr Lorenz Mayr and Dr Catherine Beech to provide scientific and strategic oversight
Cambridge, UK, 17 July 2023: PhoreMost Ltd., a leading UK biopharmaceutical company unlocking the next generation of drug targets, today announced Professor Peter Parker and Dr Jason Imbriglio as members of its Scientific Advisory Board (SAB). Professor Parker and Dr Imbriglio will join existing SAB members, Dr Simon Cook (Institute Director, Babraham Institute and PhoreMost SAB Chair), Dr Lorenz Mayr (CEO, Vector Biopharma…
Anglia Ruskin University (ARU) and Writtle University College are delighted to announce a proposal to merge the two institutions.
The proposed merger will secure a long-term, sustainable future for Writtle, and unlock significant opportunities for growth and development by bringing together the two institutions’ strengths across education and research.
Now in its 130th year and located on the outskirts of Chelmsford, Writtle University College is one of the UK’s leading institutions for land-based studies.
It offers postgraduate, undergraduate, further education and short courses in the areas…